| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.32B | +16.1% |
| Cost of Revenue | $1.55B | +20.0% |
| Gross Profit | $770.4M | +8.9% |
| R&D Expense | $16.0M | +11.9% |
| SG&A Expense | $396.0M | +39.1% |
| Operating Income | $357.4M | -7.8% |
| Interest Expense | $68.4M | +17.3% |
| Pre-tax Income | $289.0M | -12.3% |
| Income Tax | $72.8M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.8M | +1.0% |
| Accounts Receivable | $223.4M | +1.4% |
| Inventory | $330.4M | +15.5% |
| Current Assets | $665.5M | +12.3% |
| Total Assets | $941.0M | +12.4% |
| Current Liabilities | $282.8M | +38.8% |
| Long-term Debt | $1.08B | +30.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $260.6M | +30.6% |
| Investing Cash Flow | -$4.7M | -161.1% |
| Financing Cash Flow | -$238.3M | -36.1% |
| -12.2% |
| Net Income | $216.2M | -12.3% |
| EPS (Basic) | $1.70 | -10.1% |
| EPS (Diluted) | $1.68 | -9.7% |
| Total Liabilities |
| $1.39B |
| +33.8% |
| Stockholders' Equity | -$453.9M | -120.4% |